This part just blows me away.
Excluding a one-time pretax charge of $50 million for claims related to its weed killer Imprelis, DuPont says it earned $1.61 a share for the quarter.
Analysts, who typically exclude one-time charges, expected $1.55 per share, according to a poll by FactSet.
Federal environmental regulators ordered DuPont to halt sales of Imprelis last year because of reports of damage to trees, particularly evergreens, which resulted in several lawsuits against the company. DuPont said Thursday that it has charged a total of $225 million for Imprelis claims as of March 31, and that it believes total charges could range as high as $575 million. The company intends to seek recovery from insurance carriers for costs exceeding $100 million.